应对生物技术变革与伦理新挑战的中国方略
China's Strategies for Governance of Biotechnological Changes and New Ethical Challenges
China's Strategies for Governance of Biotechnological Changes and New Ethical Challenges
作者
彭耀进1,2,3(中国科学院动物研究所 北京 100101;中国科学院大学 北京 100049;北京干细胞与再生医学研究院 北京 100101)
周琪4*(中国科学院 北京 100864)
周琪4*(中国科学院 北京 100864)
中文关键词
生物技术;伦理;治理
英文关键词
biotechnology;ethics;governance
中文摘要
生物技术日新月异，给人类社会提供巨大效益，但同时其发展与变革所伴随的伦理、安全、负外部性等问题日益凸显。生物技术伦理挑战及其应对已成为当今中国国家治理体系和治理能力现代化研究的重要议题之一。当前，生物技术仍处于早期发展阶段且发展方向、路径及其应用等均具有高度不确定性，技术变革具有更强的颠覆性、复杂性和社会关联性等特征。世界正面临生物技术大发展、伦理新挑战爆发、伦理治理再变革的交织互动复杂局面。中国应借此机会一方面推动生物技术高质量发展，另一方面应从风险研判、制度构建、多元主体参与和全球治理等维度，多管齐下、交错互动，以期达到综合性、灵活性、可持续性的治理愿景。
英文摘要
Biotechnology is changing greatly over recent years, providing huge benefits to human society. However, the ethics, safety, and negative externalities of biotechnology have become increasingly prominent. Currently, biotechnology is still in the early stage of development, and full of high uncertainty. Technological changes in this field have the characteristics of stronger subversiveness, complexity, and social relevance. The world is facing a process of great development of biotechnology, new outbreaks of ethical challenges, and ethical governance reforms. China should take this opportunity to promote the high-quality development of biotechnology on the one hand, and on the other hand, adopt a multi-pronged approach to achieve comprehensive, flexible, and sustainable governance of ethical issues by conducting forward-looking ethical risk research and judgment, improving regulatory system, encouraging the participation of multiple stakeholders, and taking part in global governance, etc.
DOI10.16418/j.issn.1000-3045.20210823001
作者简介
彭耀进 中国科学院动物研究所副研究员,北京干细胞与再生医学研究院致一研究员、科技伦理研究中心主任。研究领域包括生命科技法与伦理、知识产权与标准,科技与创新政策等。
E-mail:yaojin.peng@ioz.ac.cn
PENG Yaojin Associate Professor of the Institute of Zoology (IOZ), Chinese Academy of Sciences (CAS); Zhiyi Professor at Beijing Institute for Stem Cell and Regenerative Medicine (BISCRM); Director of the Centre for Ethics of Science and Technology (CEST, BISCRM). Dr Peng holds a Bachelor's degree in life science, and Ph.D. at the Faculty of Law, Maastricht University, the Netherlands. His research focuses on legal and ethical issues in the fields of biotechnology and medicine, intellectual property law and standards, policy and management of S&T, etc.
E-mail:yaojin.peng@ioz.ac.cn
周琪 中国科学院副院长、党组成员。中国科学院院士,发展中国家科学院院士。干细胞与发育生物学专家。兼任北京干细胞与再生医学研究院理事长。研究领域包括生殖、发育、干细胞的基础研究与转化。
E-mail:zhouqi@ioz.ac.cn
ZHOU Qi Vice President of Chinese Academy of Sciences (CAS), and President of Beijing Institute for Stem Cell and Regenerative Medicine. Academician of CAS, and Fellow of the World Academy of Sciences for the advancement of science in developing countries (TWAS). As an expert in stem cell and developmental biology, Dr. Zhou has contributed significantly to the basic research of stem cell, reproductive and developmental biology, as well as to the application of stem cells to clinical use.
E-mail:zhouqi@ioz.ac.cn
E-mail:yaojin.peng@ioz.ac.cn
PENG Yaojin Associate Professor of the Institute of Zoology (IOZ), Chinese Academy of Sciences (CAS); Zhiyi Professor at Beijing Institute for Stem Cell and Regenerative Medicine (BISCRM); Director of the Centre for Ethics of Science and Technology (CEST, BISCRM). Dr Peng holds a Bachelor's degree in life science, and Ph.D. at the Faculty of Law, Maastricht University, the Netherlands. His research focuses on legal and ethical issues in the fields of biotechnology and medicine, intellectual property law and standards, policy and management of S&T, etc.
E-mail:yaojin.peng@ioz.ac.cn
周琪 中国科学院副院长、党组成员。中国科学院院士,发展中国家科学院院士。干细胞与发育生物学专家。兼任北京干细胞与再生医学研究院理事长。研究领域包括生殖、发育、干细胞的基础研究与转化。
E-mail:zhouqi@ioz.ac.cn
ZHOU Qi Vice President of Chinese Academy of Sciences (CAS), and President of Beijing Institute for Stem Cell and Regenerative Medicine. Academician of CAS, and Fellow of the World Academy of Sciences for the advancement of science in developing countries (TWAS). As an expert in stem cell and developmental biology, Dr. Zhou has contributed significantly to the basic research of stem cell, reproductive and developmental biology, as well as to the application of stem cells to clinical use.
E-mail:zhouqi@ioz.ac.cn
